763 related articles for article (PubMed ID: 9135008)
21. Protease crosstalk with integrins: the urokinase receptor paradigm.
Chapman HA; Wei Y
Thromb Haemost; 2001 Jul; 86(1):124-9. PubMed ID: 11486997
[TBL] [Abstract][Full Text] [Related]
22. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
23. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
Chavakis T; Kanse SM; May AE; Preissner KT
Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
[TBL] [Abstract][Full Text] [Related]
24. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
25. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins.
Friedlander DR; Zagzag D; Shiff B; Cohen H; Allen JC; Kelly PJ; Grumet M
Cancer Res; 1996 Apr; 56(8):1939-47. PubMed ID: 8620517
[TBL] [Abstract][Full Text] [Related]
26. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
Xue W; Kindzelskii AL; Todd RF; Petty HR
J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
[TBL] [Abstract][Full Text] [Related]
27. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.
Masumoto A; Arao S; Otsuki M
Hepatology; 1999 Jan; 29(1):68-74. PubMed ID: 9862852
[TBL] [Abstract][Full Text] [Related]
28. Divalent cations regulate the organization of integrins alpha v beta 3 and alpha v beta 5 on the cell surface.
Stuiver I; Ruggeri Z; Smith JW
J Cell Physiol; 1996 Sep; 168(3):521-31. PubMed ID: 8816906
[TBL] [Abstract][Full Text] [Related]
29. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
[TBL] [Abstract][Full Text] [Related]
30. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
[TBL] [Abstract][Full Text] [Related]
31. Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.
Hoyt DG; Rusnak JM; Mannix RJ; Modzelewski RA; Johnson CS; Lazo JS
Cancer Res; 1996 Sep; 56(18):4146-9. PubMed ID: 8797583
[TBL] [Abstract][Full Text] [Related]
32. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
Tang CH; Hill ML; Brumwell AN; Chapman HA; Wei Y
J Cell Sci; 2008 Nov; 121(Pt 22):3747-56. PubMed ID: 18940913
[TBL] [Abstract][Full Text] [Related]
33. AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.
Piao Y; Lu L; de Groot J
Neuro Oncol; 2009 Jun; 11(3):260-73. PubMed ID: 18957620
[TBL] [Abstract][Full Text] [Related]
34. Role of laminin-binding integrin in the invasion of basement membrane matrices by fibrosarcoma cells.
Ramos DM; Cheng YF; Kramer RH
Invasion Metastasis; 1991; 11(3):125-38. PubMed ID: 1938274
[TBL] [Abstract][Full Text] [Related]
35. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
Pliyev BK; Antonova OA; Menshikov M
Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
[TBL] [Abstract][Full Text] [Related]
36. Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of alpha 1 beta 1, alpha 6 beta 1, and alpha v beta 5 integrins.
Pirilä L; Heino J
J Rheumatol; 1996 Oct; 23(10):1691-8. PubMed ID: 8895142
[TBL] [Abstract][Full Text] [Related]
37. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton.
Artym VV; Kindzelskii AL; Chen WT; Petty HR
Carcinogenesis; 2002 Oct; 23(10):1593-601. PubMed ID: 12376466
[TBL] [Abstract][Full Text] [Related]
38. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
Planus E; Barlovatz-Meimon G; Rogers RA; Bonavaud S; Ingber DE; Wang N
J Cell Sci; 1997 May; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration.
Yamada KM; Kennedy DW; Yamada SS; Gralnick H; Chen WT; Akiyama SK
Cancer Res; 1990 Aug; 50(15):4485-96. PubMed ID: 2369727
[TBL] [Abstract][Full Text] [Related]
40. Growth cone migration across extracellular matrix components depends on integrin, but migration across glioma cells does not.
Letourneau PC; Pech IV; Rogers SL; Palm SL; McCarthy JB; Furcht LT
J Neurosci Res; 1988; 21(2-4):286-97. PubMed ID: 3265160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
